Dyanavel XR
NDC 24478-102, amphetamine, suspension, extended release, from NextWave Pharmaceuticals, Inc.
- Product NDC
- 24478-102
- Status
- Listed
- Labeler
- NextWave Pharmaceuticals, Inc
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208147
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/24478-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMPHETAMINE2.5 mg/mL
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24478-102-01 | 24478010201 | 1 BOTTLE in 1 CARTON (24478-102-01) / 464 mL in 1 BOTTLE |
| 24478-102-02 | 24478010202 | 1 BOTTLE in 1 CARTON (24478-102-02) / 60 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ae304b29-0b40-40ec-ad0d-76b742d4a9b9NADAC price for package 24478010201
GET /v1/drugs/nadac/24478010201NADAC price for package 24478010202
GET /v1/drugs/nadac/24478010202
Use it
Look up 24478-102 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24478-102 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24478-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.